Logo do repositório
 
Publicação

The importance of co-produced, multi-method, independent scientific evidence in times of alternative truths and global policy debates

datacite.subject.fosCiências Sociais::Psicologia
datacite.subject.sdg03:Saúde de Qualidade
dc.contributor.authorComiskey, Catherine
dc.contributor.authorBergeron, Henri
dc.contributor.authorClausen, Thomas
dc.contributor.authorColman, Charlotte
dc.contributor.authorFerrer-Wreder, Laura
dc.contributor.authorFischer, Gabriele
dc.contributor.authorGaspar de Matos, Margarida
dc.contributor.authorIvers, Jo-Hanna
dc.contributor.authorJauffret-Roustide, Marie
dc.contributor.authorLiem, Marieke
dc.contributor.authorLintonen, Tomi
dc.contributor.authorMoeller, Kim
dc.contributor.authorOjanperä, Ilkka
dc.contributor.authorFonseca, Fernando Rodríguez de
dc.contributor.authorMèlich, Marta Torrens
dc.date.accessioned2026-07-09T18:39:40Z
dc.date.available2026-07-09T18:39:40Z
dc.date.issued2024-07
dc.description.abstractIn July 2024 the long established and trusted European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) will cease to exist and will evolve to the new European Drugs Agency (EUDA). In response to the ever diversifying, innovative and complex drug phenomena, the EUDA will open with considerably more powers, new methodological tools, and a proactive remit to support preparedness, monitoring and competence development of policy makers, practitioners and researchers (EMCDDA, 2024). This expanded mandate includes threat assessments and alerts; monitoring and addressing poly-substance use; setting up a network of forensic laboratories; developing and promoting best practice; supporting independent evaluation of drug polices and playing a stronger international role within this remit in the EU. As the old adage coined by notaries from Voltaire to Spiderman have said, “with great power comes great responsibility”, and it is in times of global policy pressure from so called ‘fake news’ to Artificial Intelligence generated data and conspiracy theories that the need for trusted, independent scientific evidence has never been greater.eng
dc.identifier.citationComiskey, C., Bergeron, H., Clausen, T., Colman, C., Ferrer-Wreder, L., Fischer, G., De Matos, M. G., Ivers, J., Jauffret-Roustide, M., Liem, M., Lintonen, T., Moeller, K., Ojanperä, I., De Fonseca, F. R., & Mèlich, M. T. (2024). The importance of co-produced, multi-method, independent scientific evidence in times of alternative truths and global policy debates. International Journal of Drug Policy, 129, 104481. https://doi.org/10.1016/j.drugpo.2024.104481
dc.identifier.doi10.1016/j.drugpo.2024.104481
dc.identifier.issn0955-3959
dc.identifier.urihttp://hdl.handle.net/10400.12/14022
dc.language.isoeng
dc.peerreviewedyes
dc.publisherElsevier BV
dc.relation.ispartofInternational Journal of Drug Policy
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleThe importance of co-produced, multi-method, independent scientific evidence in times of alternative truths and global policy debates
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage2
oaire.citation.startPage1
oaire.citation.volume129
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
international Journal or Drug Policy.pdf
Tamanho:
280.99 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
4.03 KB
Formato:
Item-specific license agreed upon to submission
Descrição: